Molecular mechanisms regulating macrophage response to hypoxia

Frontiers in Immunology

Volumn 2, Issue SEP, 2011, Pages

  Rahat, Michal A ^a   Bitterman, Haim ^a   Lahat, Nitza ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Inflammation; Low oxygen tension; M1 macrophages; M2 macrophages; Post transcriptional regulation; Post translational regulation

Indexed keywords

EID: 84873864037     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00045     Document Type: Review

References (147)

1. Acosta-Iborra, B., Elorza, A., Olaza-bal, I. M., Martin-Cofreces, N. B., Martin-Puig, S., Miro, M., Calzada, M. J., Aragones, J., Sanchez-Madrid, F., and Landazuri, M. O. (2009). Macrophage oxygen sensing mod-ulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J. Immunol. 182, 3155-3164.
2. Albina, J. E., Henry, W. L. Jr., Mas-trofrancesco, B., Martin, B. A., and Reichner, J. S. (1995). Macrophage activation by culture in an anoxic environment. J. Immunol. 155, 4391-4396.
3. Albina, J. E., Mahoney, E. J., Daley, J. M., Wesche, D. E., Morris, S. M. Jr., and Reichner, J. S. (2005). Macrophage arginase regulation by CCAAT/enhancer-binding protein beta. Shock 23, 168-172.
4. Alfranca, A., Gutierrez, M. D., Vara, A., Aragones, J., Vidal, F., and Landazuri, M. O. (2002). c-Jun and hypoxia-inducible factor 1 functionally coop-erate in hypoxia-induced gene tran-scription. Mol. Cell. Biol. 22, 12-22.
5. Auffray, C., Sieweke, M. H., and Geiss-mann, F. (2009). Blood mono-cytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
6. Bandyopadhyay, R. S., Phelan, M., and Faller, D. V. (1995). Hypoxia induces AP-1-regulated genes and AP-1 tran-scription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1264, 72-78.
7. Behn, C., Araneda, O. F., Llanos, A. J., Celedon, G., and Gonzalez, G. (2007). Hypoxia-related lipid perox-idation: evidences, implications and approaches. Respir. Physiol. Neuro-biol. 158, 143-150.
8. Belaiba, R. S., Bonello, S., Zahringer, C., Schmidt, S., Hess, J., Kietzmann, T., and Gorlach, A. (2007). Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell 18, 4691-4697.
9. Biswas, S. K., and Lewis, C. E. (2010). NF-kappaB as a central regulator of macrophage function in tumors. J. Leukoc. Biol. 88, 877-884.
10. Bosco, M. C., Puppo, M., Blengio, F., Fraone, T., Cappello, P., Giovarelli, M., and Varesio, L. (2008). Mono-cytes and dendritic cells in a hypoxic environment: spotlights on chemo-taxis and migration. Immunobiology 213, 733-749.
11. Bosco, M. C., Puppo, M., Pas-torino, S., Mi, Z., Melillo, G., Massazza, S., Rapisarda, A., and Varesio, L. (2004). Hypoxia selec-tively inhibits monocyte chemoat-tractant protein-1 production by macrophages. J. Immunol. 172, 1681-1690.
12. Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., Battaglia, F., and Varesio, L. (2006). Hypoxia modifies the tran-scriptome of primary human mono-cytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 177, 1941-1955.
13. Bronte, V. (2009). Myeloid-derived suppressor cells in inflamma-tion: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39, 2670-2672.
14. Burke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M., and Lewis, C. E. (2002). Expres-sion of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196, 204-212.
15. Bystrom, J., Evans, I., Newson, J., Sta-bles, M., Toor, I., Van Rooijen, N., Crawford, M., Colville-Nash, P., Far-row, S., and Gilroy, D. W. (2008). Resolution-phase macrophages pos-sess a unique inflammatory pheno-type that is controlled by cAMP. Blood 112, 4117-4127.
16. Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silber-stein, S., Stalla, G. K., Holsboer, F., and Arzt, E. (2007). RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131, 309-323.
17. Chandel, N. S., Trzyna, W. C., Mcclin-tock, D. S., and Schumacker, P. T. (2000). Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 165, 1013-1021.
18. Cheng, J., Kang, X., Zhang, S., and Yeh, E. T. (2007). SUMO-specific pro-tease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131, 584-595.
19. Cho, H., Ahn, D. R., Park, H., and Yang, E. G. (2007). Modulation of p300 binding by posttranslational modifi-cations of the C-terminal activation domain of hypoxia-inducible factor-1alpha. FEBS Lett. 581, 1542-1548.
20. Cockman, M. E., Lancaster, D. E., Stolze, I. P., Hewitson, K. S., Mcdonough, M. A., Coleman, M. L., Coles, C. H., Yu, X., Hay, R. T., Ley, S. C., Pugh, C. W., Oldham, N. J., Mas-son, N., Schofield, C. J., and Rat-cliffe, P. J. (2006). Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. U.S.A. 103, 14767-14772.
21. Coffelt, S. B., Hughes, R., and Lewis, C. E. (2009). Tumor-associated macrophages: effectors of angiogen-esis and tumor progression. Biochim. Biophys. Acta 1796, 11-18.
22. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mack-man, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., Firestein, G. S., Gerber, H. P., Ferrara, N., and John-son, R. S. (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
23. Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S. Y., Senechal, B., Puel, A., Biswas, S. K., Moshous, D., Picard, C., Jais, J. P., D'cruz, D., Casanova, J. L., Trouillet, C., and Geissmann, F. (2010). Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33, 375-386.
24. Crowther, M., Brown, N. J., Bishop, E. T., and Lewis, C. E. (2001). Microenvironmental influence on macrophage regulation of angio-genesis in wounds and malignant tumors. J. Leukoc. Biol. 70, 478-490.
25. Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., and Taylor, C. T. (2006). Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. U.S.A. 103, 18154-18159.
26. Daniliuc, S., Bitterman, H., Rahat, M. A., Kinarty, A., Rosenzweig, D., and Lahat, N. (2003). Hypoxia inacti-vates inducible nitric oxide synthase in mouse macrophages by disrupt-ing its interaction with alpha-actinin 4. J. Immunol. 171, 3225-3232.
27. De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L., and Lewis, C. E. (2007). Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519-524.
28. Demasi, M., Cleland, L. G., Cook-Johnson, R. J., Caughey, G. E., and James, M. J. (2003). Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthe-sis. J. Biol. Chem. 278, 38607-38616.
29. Denko, N. C. (2008). Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705-713.
30. Dlaska, M., and Weiss, G. (1999). Cen-tral role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162, 6171-6177.
31. Elbarghati, L., Murdoch, C., and Lewis, C. E. (2008). Effects of hypoxia on transcription factor expres-sion in human monocytes and macrophages. Immunobiology 213, 899-908.
32. Eltzschig, H. K. (2011). Targeting hypoxia-induced inflammation. Anesthesiology 114, 239-242.
33. Fang, H. Y., Hughes, R., Murdoch, C., Coffelt, S. B., Biswas, S. K., Harris, A. L., Johnson, R. S., Imityaz, H. Z., Simon, M. C., Fredlund, E., Greten, F. R., Rius, J., and Lewis, C. E. (2009). Hypoxia-inducible factors 1 and 2 are important transcriptional effec-tors in primary macrophages experi-encing hypoxia. Blood 114, 844-859.
34. Fitzpatrick, S. F., Tambuwala, M. M., Bruning, U., Schaible, B., Scholz, C. C., Byrne, A., O'connor, A., Gal-lagher, W. M., Lenihan, C. R., Gar-vey, J. F., Howell, K., Fallon, P. G., Cummins, E. P., and Taylor, C. T. (2011). An intact canoni-cal NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. J. Immunol. 186, 1091-1096.
35. Flugel, D., Gorlach, A., Michiels, C., and Kietzmann, T. (2007). Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol. Cell. Biol. 27, 3253-3265.
36. Fong, C. H., Bebien, M., Didierlau-rent, A., Nebauer, R., Hussell, T., Broide, D., Karin, M., and Lawrence, T. (2008). An antiinflammatory role for IKKbeta through the inhibition of "classical"macrophage activation. J. Exp. Med. 205, 1269-1276.
37. Frede, S., Stockmann, C., Freitag, P., and Fandrey, J. (2006). Bacter-ial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem. J. 396, 517-527.
38. Frede, S., Stockmann, C., Winning, S., Freitag, P., and Fandrey, J. (2009). Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin toler-ance. J. Immunol. 182, 6470-6476.
39. Gabrilovich, D. I., and Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune sys-tem. Nat. Rev. Immunol. 9, 162-174.
40. Galban, S., and Gorospe, M. (2009). Factors interacting with HIF-1alpha mRNA: novel therapeutic targets. Curr. Pharm. Des. 15, 3853-3860.
41. Galban, S., Kuwano, Y., Pullmann, R. Jr., Martindale, J. L., Kim, H. H., Lal, A., Abdelmohsen, K., Yang, X., Dang, Y., Liu, J. O., Lewis, S. M., Holcik, M., and Gorospe, M. (2008). RNA-binding proteins HuR and PTB pro-mote the translation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 28, 93-107.
42. Geissmann, F., Jung, S., and Littman, D. R. (2003). Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
43. Gordon, S., and Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and func-tions. Immunity 32, 593-604.
44. Gorgoni, B., Maritano, D., Marthyn, P., Righi, M., and Poli, V. (2002). C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J. Immunol. 168, 4055-4062.
45. Griffiths, L., Binley, K., Iqball, S., Kan, O., Maxwell, P., Ratcliffe, P., Lewis, C., Harris, A., Kingsman, S., and Naylor, S. (2000). The macrophage -a novel system to deliver gene ther-apy to pathological hypoxia. Gene Ther. 7, 255-262.
46. Grivennikov, S. I., and Karin, M. (2010). Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21, 11-19.
47. Grocott, M. P., Martin, D. S., Levett, D. Z., Mcmorrow, R., Windsor, J., and Montgomery, H. E. (2009). Arterial blood gases and oxygen content in climbers on Mount Everest. N. Engl. J. Med. 360, 140-149.
48. Guida, E., and Stewart, A. (1998). Influ-ence of hypoxia and glucose depri-vation on tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor expres-sion in human cultured monocytes. Cell. Physiol. Biochem. 8, 75-88.
49. Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., and Lewis, C. E. (2009). Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 113, 3139-3146.
50. Hartmann, G., Tschop, M., Fischer, R., Bidlingmaier, C., Riepl, R., Tschop, K., Hautmann, H., Endres, S., and Toepfer, M. (2000). High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12, 246-252.
51. Heikkila, M., Pasanen, A., Kivirikko, K. I., and Myllyharju, J. (2011). Roles of the human hypoxia-inducible fac-tor (HIF)-3alpha variants in the hypoxia response. Cell. Mol. LifeSci. PMID: 21479871. [Epub ahead of print].
52. Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., and Abraham, R. T. (2002). Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7004-7014.
53. Ivanov, S. V., Salnikow, K., Ivanova, A. V., Bai, L., and Lerman, M. I. (2007). Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene 26, 802-812.
54. Jafarifar, F., Yao, P., Eswarappa, S. M., and Fox, P. L. (2011). Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30, 1324-1334.
55. Janardhan, H. P. (2008). The HIF-1alpha-C/EBP alpha axis. Sci. Signal. 1, jc2.
56. Kang, S. H., Yu, M. O., Park, K. J., Chi, S. G., Park, D. H., and Chung, Y. G. (2010). Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblas-toma. Neurosurgery 67, 1386-1395; discussion 1395.
57. Khabar, K. S. (2010). Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell. Mol. Life Sci. 67, 2937-2955.
58. Kim, D., Kim, Y. J., Koh, H. S., Jang, T. Y., Park, H. E., and Kim, J. Y. (2010). Reactive oxygen species enhance TLR10 expression in the human monocytic cell line THP-1. Int. J. Mol. Sci. 11, 3769-3782.
59. Laderoute, K. R. (2005). The interac-tion between HIF-1 and AP-1 tran-scription factors in response to low oxygen. Semin. Cell Dev. Biol. 16, 502-513.
60. Laderoute, K. R., Alarcon, R. M., Brody, M. D., Calaoagan, J. M., Chen, E. Y., Knapp, A. M., Yun, Z., Denko, N. C., and Giaccia, A. J. (2000). Oppos-ing effects of hypoxia on expres-sion of the angiogenic inhibitor thrombospondin 1 and the angio-genic inducer vascular endothelial growth factor. Clin. Cancer Res. 6, 2941-2950.
61. Lahat, N., Bitterman, H., Engelmayer-Goren, M., Rosenzweig, D., Weiss-Cerem, L., and Rahat, M. A. (2011). Reduced TIMP-2 in hypoxia enhances angiogenesis. Am.J. Phys-iol. Cell Physiol. 300, C557-C566.
62. Lahat, N., Rahat, M. A., Ballan, M., Weiss-Cerem, L., Engelmayer, M., and Bitterman, H. (2003). Hypoxia reduces CD80 expres-sion on monocytes but enhances their LPS-stimulated TNF-alpha secretion. J. Leukoc. Biol. 74, 197-205.
63. Lahat, N., Rahat, M. A., Kinarty, A., Weiss-Cerem, L., Pinchevski, S., and Bitterman, H. (2008). Hypoxia enhances lysosomal TNF-alpha degradation in mouse peri-toneal macrophages. Am. J. Physiol., Cell Physiol. 295, C2-C12.
64. Lawrence, T., and Fong, C. (2010). The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int. J. Biochem. Cell Biol. 42, 519-523.
65. Lee, K. J., Lee, K. Y., and Lee, Y. M. (2010). Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Biochim. Biophys. Acta 1803, 608-616.
66. Lee, M. Y., Joung, Y. H., Lim, E. J., Park, J. H., Ye, S. K., Park, T., Zhang, Z., Park, D. K., Lee, K. J., and Yang, Y. M. (2006). Phosphorylation and activa-tion of STAT proteins by hypoxia in breast cancer cells. Breast 15, 187-195.
67. Leeper-Woodford, S. K., and Detmer, K. (1999). Acute hypoxia increases alveolar macrophage tumor necro-sis factor activity and alters NF-kappaB expression. Am. J. Physiol. 276, L909-L916.
68. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in dif-ferent tumor microenvironments. Cancer Res. 66, 605-612.
69. Lewis, J. S., Lee, J. A., Underwood, J. C., Harris, A. L., and Lewis, C. E. (1999). Macrophage responses to hypoxia: relevance to disease mechanisms. J. Leukoc. Biol. 66, 889-900.
70. Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., and Li, C.Y. (2007). Regulation of HIF-1alpha stability through S-nitrosylation. Mol. Cell 26, 63-74.
71. Li, P., Lu, J., Kaur, C., Sivakumar, V., Tan, K. L., and Ling, E. A. (2009). Expres-sion of cyclooxygenase-1/-2, micro-somal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory medi-ators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells. Neuroscience 164, 948-962.
72. Li, S. H., Chun, Y. S., Lim, J. H., Huang, L. E., and Park, J. W. (2011). von Hippel-Lindau protein adjusts oxy-gen sensing of the FIH asparaginyl hydroxylase. Int. J. Biochem. Cell Biol. 43, 795-804.
73. Liao, H., Hyman, M. C., Lawrence, D. A., and Pinsky, D. J. (2007). Molecular regulation of the PAI-1 gene by hypoxia: contri-butions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J. 21, 935-949.
74. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., and Semenza, G. L. (2011). Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744.
75. Mancino, A., and Lawrence, T. (2010). Nuclear factor-kappaB and tumor-associated macrophages. Clin. Can-cer Res. 16, 784-789.
76. Martinez, F. O., Helming, L., and Gor-don, S. (2009). Alternative activa-tion of macrophages: an immuno-logic functional perspective. Annu. Rev. Immunol. 27, 451-483.
77. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461.
78. Matzinger, P. (2002). The danger model: a renewed sense of self. Science 296, 301-305.
79. Melillo, G., Taylor, L. S., Brooks, A., Cox, G. W., and Varesio, L. (1996). Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cul-tured under hypoxic conditions. J. Immunol. 157, 2638-2644.
80. Meng, X., Ao, L., Shames, B. D., and Harken, A. H. (2001). Inhibition of cyclic-3′,5′-nucleotide phospho-diesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production. J. Surg. Res. 101, 210-215.
81. Minko, T., Wang, Y., and Pozharov, V. (2005). Remediation of cellular hypoxic damage by pharmacolog-ical agents. Curr. Pharm. Des. 11, 3185-3199.
82. Mosser, D. M. (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
83. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
84. Murdoch, C., Giannoudis, A., and Lewis, C. E. (2004). Mechanisms regulat-ing the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104, 2224-2234.
85. Murdoch, C., Muthana, M., Coffelt, S. B., and Lewis, C. E. (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618-631.
86. Murdoch, C., Muthana, M., and Lewis, C. E. (2005). Hypoxia regulates macrophage functions in inflamma-tion. J. Immunol. 175, 6257-6263.
87. Mylonis, I., Chachami, G., Samio-taki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., and Simos, G. (2006). Identification of MAPK phospho-rylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J. Biol. Chem. 281, 33095-33106.
88. Nahid, M. A., Pauley, K. M., Satoh, M., and Chan, E. K. (2009). miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 284, 34590-34599.
89. Nahid, M. A., Satoh, M., and Chan, E. K. (2011). Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186, 1723-1734.
90. Nahrendorf, M., Pittet, M. J., and Swirski, F. K. (2010). Monocytes: protagonists of infarct inflammation and repair after myocardial infarc-tion. Circulation 121, 2437-2445.
91. Niu, G., Briggs, J., Deng, J., Ma, Y., Lee, H., Kortylewski, M., Kujawski, M., Kay, H., Cress, W. D., Jove, R., and Yu, H. (2008). Signal trans-ducer and activator of transcrip-tion 3 is required for hypoxia-inducible factor-1alpha RNA expres-sion in both tumor cells and tumor-associated myeloid cells. Mol. Cancer Res. 6, 1099-1105.
92. Nizet, V., and Johnson, R. S. (2009). Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609-617.
93. Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., Giuliani, M., Pichon, C., Azzarone, B., Mazure, N., Romero, P., Mami-Chouaib, F., and Chouaib, S. (2009). The coopera-tive induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J. Immunol. 182, 3510-3521.
94. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., and Bal-timore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 104, 1604-1609.
95. Oda, T., Hirota, K., Nishi, K., Tak-abuchi, S., Oda, S., Yamada, H., Arai, T., Fukuda, K., Kita, T., Adachi, T., Semenza, G. L., and Nohara, R. (2006). Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am. J. Physiol. Cell Physiol. 291, C104-C113.
96. Ostrand-Rosenberg, S., and Sinha, P. (2009). Myeloid-derived suppressor cells: linking inflammation and can-cer. J. Immunol. 182, 4499-4506.
97. Papandreou, I., Powell, A., Lim, A. L., and Denko, N. (2005). Cellu-lar reaction to hypoxia: sensing and responding to an adverse environ-ment. Mutat. Res. 569, 87-100.
98. Patel, S. A., and Simon, M. C. (2008). Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ. 15, 628-634.
99. Pautz, A., Art, J., Hahn, S., Nowag, S., Voss, C., and Kleinert, H. (2010). Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23, 75-93.
100. Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., and Nizet, V. (2007). Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516-7519.
101. Pocock, R. (2011). Invited review: decoding the microRNA response to hypoxia. Pflugers Arch. 461,307-315.
102. Qian, B. Z., and Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
103. Qu, X., Yang, M. X., Kong, B. H., Qi, L., Lam, Q. L., Yan, S., Li, P., Zhang, M., and Lu, L. (2005). Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol. Cell Biol. 83, 668-673.
104. Rahat, M. A., Marom, B., Bitterman, H., Weiss-Cerem, L., Kinarty, A., and Lahat, N. (2006). Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secre-tion and elevating membranal asso-ciation. J. Leukoc. Biol. 79, 706-718.
105. Ramanathan, M., Luo, W., Csoka, B., Hasko, G., Lukashev, D., Sitkovsky, M. V., and Leibovich, S. J. (2009). Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adeno-sine A(2A) receptor agonists. J. Leukoc. Biol. 86, 681-689.
106. Ray, P. S., Jia, J., Yao, P., Majumder, M., Hatzoglou, M., and Fox, P. L. (2009). A stress-responsive RNA switch reg-ulates VEGFA expression. Nature 457, 915-919.
107. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., and Karin, M. (2008). NF-kappaB links innate immunity to the hypoxic response through transcrip-tional regulation of HIF-1alpha. Nature 453, 807-811.
108. Rosenberger, P., Schwab, J. M., Mirakaj, V., Masekowsky, E., Mager, A., Morote-Garcia, J. C., Unertl, K., and Eltzschig, H. K. (2009). Hypoxia-inducible factor-dependent induc-tion of netrin-1 dampens inflam-mation caused by hypoxia. Nat. Immunol. 10, 195-202.
109. Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., and Sica, A. (2006). p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflamma-tory responses and antitumor resis-tance. Cancer Res. 66, 11432-11440.
110. Sakamoto, T., and Seiki, M. (2010). A membrane protease regulates energy production in macrophages by acti-vating hypoxia-inducible factor-1 via a non-proteolytic mechanism. J. Biol. Chem. 285, 29951-29964.
111. Scannell, G., Waxman, K., Kaml, G. J., Ioli, G., Gatanaga, T., Yamamoto, R., and Granger, G. A. (1993). Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble recep-tors in vitro. J. Surg. Res. 54, 281-285.
112. Schif-Zuck, S., Gross, N., Assi, S., Ros-toker, R., Serhan, C. N., and Ariel, A. (2011). Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41, 366-379.
113. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapis-arda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., and Sica, A. (2003). Regulation of the chemokine recep-tor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
114. Schroder, K., Sweet, M. J., and Hume, D. A. (2006). Signal integration between IFNgamma and TLR sig-nalling pathways in macrophages. Immunobiology 211, 511-524.
115. Shin, I. J., Park, B. K., Ahn, Y. T., Kim, Y., and An, W. G. (2010). Actin disruption inhibits hypoxia inducible factor-1alpha expression via inactivity of Mdm2-mediated p70S6K. Mol. Med. Report 3, 815-819.
116. Shirato, K., Kizaki, T., Sakurai, T., Ogasawara, J. E., Ishibashi, Y., Iijima, T., Okada, C., Noguchi, I., Imaizumi, K., Taniguchi, N., and Ohno, H. (2009). Hypoxia-inducible factor-1alpha suppresses the expression of macrophage scav-engerreceptor1. Pflugers Arch. 459, 93-103.
117. Sica, A., Allavena, P., and Mantovani, A. (2008). Cancer related inflamma-tion: the macrophage connection. Cancer Lett. 267, 204-215.
118. Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., and Mantovani, A. (2000). Autocrine production of IL-10 mediates defective IL-12 pro-duction and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 164, 762-767.
119. Skrzeczynska-Moncznik, J., Bzowska, M., Loseke, S., Grage-Griebenow, E., Zembala, M., and Pryjma, J. (2008). Peripheral blood CD14high CD16+ monocytes are main pro-ducers of IL-10. Scand. J. Immunol. 67, 152-159.
120. Sow, F. B., Alvarez, G. R., Gross, R. P., Satoskar, A. R., Schlesinger, L. S., Zwilling, B. S., and Lafuse, W. P. (2009). Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hep-cidin by mycobacterial infection and IFN-gamma. J. Leukoc. Biol. 86, 1247-1258.
121. Sperandio, S., Fortin, J., Sasik, R., Robitaille, L., Corbeil, J., and De Belle, I. (2009). The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia. Mol. Carcinog. 48, 38-44.
122. Staples, K. J., Sotoodehnejadnemata-lahi, F., Pearson, H., Frankenberger, M., Francescut, L., Ziegler-Heitbrock, L., and Burke, B. (2010). Monocyte-derived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1alpha mRNA. Immunobiology 216, 832-839.
123. Stout, R. D., and Suttles, J. (2004). Func-tional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
124. Stout, R. D., Watkins, S. K., and Suttles, J. (2009). Functional plasticity of macrophages: in situ repro-gramming of tumor-associated macrophages. J. Leukoc. Biol. 86, 1105-1109.
125. Sumbayev, V. V., Budde, A., Zhou, J., and Brune, B. (2003). HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett. 535, 106-112.
126. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486.
127. Takeda, K., Ichiki, T., Narabayashi, E., Inanaga, K., Miyazaki, R., Hashimoto, T., Matsuura, H., Ikeda, J., Miyata, T., and Sunagawa, K. (2009). Inhibition of prolyl hydroxy-lase domain-containing protein sup-pressed lipopolysaccharide-induced TNF-alpha expression. Arterioscler. Thromb. Vasc. Biol. 29, 2132-2137.
128. Takeda, N., O'dea, E. L., Doedens, A., Kim, J. W., Weidemann, A., Stock-mann, C., Asagiri, M., Simon, M. C., Hoffmann, A., and Johnson, R. S. (2010). Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24, 491-501.
129. Thulasingam, S., Massilamany, C., Gan-gaplara, A., Dai, H., Yarbaeva, S., Subramaniam, S., Riethoven, J. J., Eudy, J., Lou, M., and Reddy, J. (2011). miR-27b*, an oxidative stress-responsive microRNA modu-lates nuclear factor-kB pathway in RAW 264.7 cells. Mol. Cell. Biochem. 352, 181-188.
130. Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
131. van de Veerdonk, F. L., and Netea, M. G. (2010). Diversity: a hallmark of monocyte society. Immunity 33, 289-291.
132. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007). Switching from repres-sion to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
133. Venneri, M. A., De Palma, M., Pon-zoni, M., Pucci, F., Scielzo, C., Zonari, E., Mazzieri, R., Doglioni, C., and Naldini, L. (2007). Iden-tification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109, 5276-5285.
134. Walmsley, S. R., Chilvers, E. R., and Whyte, M. K. (2009). Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function. Arthritis Res. Ther. 11, 219.
135. Walmsley, S. R., Mcgovern, N. N., Whyte, M. K., and Chilvers, E. R. (2008). The HIF/VHL path-way: from oxygen sensing to innate immunity. Am. J. Respir. Cell Mol. Biol. 38, 251-255.
136. Weigert, A., and Brune, B. (2008). Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19, 95-102.
137. Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., and Brune, B. (2010a). Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31, 1863-1872.
138. Werno, C., Schmid, T., Schnitzer, S. E., Peters, K., Milke, L., and Brune, B. (2010b). A combination of hypoxia and lipopolysaccharide acti-vates tristetraprolin to destabilize proinflammatory mRNAs such as tumor necrosis factor-alpha. Am. J. Pathol. 177, 1104-1112.
139. Westra, J., Brouwer, E., Van Roosmalen, I. A., Doornbos-Van Der Meer, B., Van Leeuwen, M. A., Posthu-mus, M. D., and Kallenberg, C. G. (2010). Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; signifi-cant reduction of VEGF by CaMKII inhibitor. BMC Musculoskelet. Dis-ord. 11, 61. doi: 10.1186/1471-2474-11-61.
140. Xu, Y., Toure, F., Qu, W., Lin, L., Song, F., Shen, X., Rosario, R., Gar-cia, J., Schmidt, A. M., and Yan, S. F. (2010). Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages. J. Biol. Chem. 285, 23233-23240.
141. Yang, L., Jiang, Y., Wu, S. F., Zhou, M. Y., Wu, Y. L., and Chen, G. Q. (2008). CCAAT/enhancer-binding protein alpha antagonizes transcrip-tional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis 29, 291-298.
142. Yee Koh, M., Spivak-Kroizman, T. R., and Powis, G. (2008). HIF-1 regu-lation: not so easy come, easy go. Trends Biochem. Sci. 33, 526-534.
143. Yoon, S. O., Shin, S., and Mercurio, A. M. (2005). Hypoxia stimulates carci-noma invasion by stabilizing micro-tubules and promoting the Rab11 trafficking of the alpha6beta4 inte-grin. Cancer Res. 65, 2761-2769.
144. Yun, J. K., Mccormick, T. S., Villabona, C., Judware, R. R., Espinosa, M. B., and Lapetina, E. G. (1997). Inflam-matory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc. Natl. Acad. Sci. U.S.A. 94, 13903-13908.
145. Zampetaki, A., Mitsialis, S. A., Pfeilschifter, J., and Kourem-banas, S. (2004). Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/p44 and PI3 kinase pathways. FASEB J. 18, 1090-1092.
146. Zhao, P., Li, X. G., Yang, M., Shao, Q., Wang, D., Liu, S., Song, H., Song, B., Zhang, Y., and Qu, X. (2008). Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol. Immunol. 45, 2187-2195.
147. Ziegler-Heitbrock, L. (2007). The CD14+ CD16+ blood mono-cytes: their role in infection and inflammation. J. Leukoc. Biol. 81, 584-592.